SAM
CELG

Shamrock Asset Management’s Celgene Corp CELG Stock Holding History

Shamrock Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-285
Closed -$42K – 301
2017
Q3 		$42K Hold
285
– – 0.03% 138
2017
Q2 		$37K Hold
285
– – 0.02% 156
2017
Q1 		$35K Buy
+285
New +$34.1K 0.02% 153
2014
Q3 		– Sell
-200
Closed -$17K – 308
2014
Q2 		$17K Hold
200
– – 0.01% 221
2014
Q1 		$14K Buy
+200
New +$15.8K ﹤0.01% 221

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Shamrock Asset Management's CELG Position: Q4 2017 in Review

Shamrock Asset Management sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 285 shares — an estimated $42K sold.

Shamrock Asset Management first reported a position in CELG in Q1 2014 and held it in 5 quarters. The position peaked at $42K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Shamrock Asset Management reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Shamrock Asset Management sold 285 Celgene Corp shares in Q4 2017, an estimated $42K.
  • Shamrock Asset Management first reported a position in Celgene Corp in Q1 2014 and held it in 5 quarters.
  • Shamrock Asset Management's Celgene Corp position peaked at $42K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Shamrock Asset Management's 13F filing for Q4 2017, filed 22 Jan 2018.